La Renon Healthcare Pvt. Ltd, a Ahmedabad, India-based pharmaceutical research, marketing and manufacturing company, secured INR 100 crore in Series A funding.
The investor was Sequoia Capital.
The company will use the investment to enhance its Research and Development capabilities and to expand into new categories within the chronic diseases management space.
Founded by Pankaj Singh, Chairman and CEO, La Renon provides pharmaceutical products and services for various critical illnesses and diseases. Started in 2008, it focuses on early stage Chronic Kidney Disease (CKD) Patients, which is one of the most neglected segments in India, and a leader in the field of Nephrology, as well as Critical Care, Neurological Disorders and Urology.
The company, which now plans to enter new segments of chronic diseases such as Gastroenterology and Respiratory, has a 500 strong team and currently has 164 products that are distributed through approximately 400 stockists across the country.